MigraineMind research summary
Short-Term Changes in Migraine Burden After Roux-en-Y Gastric Bypass: A Prospective Cohort Study.
Obes Surg | 2026
Observational studySummary
Obesity is linked to more frequent and severe migraines. Roux-en-Y gastric bypass may help reduce migraine burden. This study involved 52 adults with severe obesity and established migraines. Participants underwent surgery and were assessed preoperatively and three months after. Researchers used various tools to measure migraine frequency, severity, and quality of life. Results showed significant body weight loss of 29 kg and BMI reduction of 11 kg/m². Migraine frequency dropped from 15 to 5 episodes. Pain severity decreased from 7.2 to 3.7, indicating less discomfort. Disability scores improved significantly, falling from 94 to 35. Quality of life also improved, with scores decreasing from 53 to 31. Notably, these improvements were not linked to age or weight loss magnitude. This highlights that metabolic surgery can significantly reduce migraine burden in obese patients. Longer studies are needed to confirm these findings and understand the relationship better. Clinical relevance: This research shows that Roux-en-Y gastric bypass can significantly reduce migraine burden in obese patients, leading to improved quality of life.
Key Learning Points
- Obesity is associated with more frequent and severe migraines, making weight management important for migraine sufferers.
- Roux-en-Y gastric bypass surgery can lead to significant reductions in migraine frequency and severity.
- Participants in the study lost an average of 29 kg after surgery, which contributed to their improved migraine outcomes.
- Quality of life improved significantly for patients after surgery, indicating a broader benefit beyond just migraine relief.
- Further research is needed to explore the long-term effects of metabolic surgery on migraines and the underlying mechanisms involved.
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.